Furthermore, we found that canagliflozin normalized the expression of transforming growth factor (TGF)-β1, a key cytokine that mediates extracellular matrix accumulation and glomerular expansion in diabetes, and the expression of fibronectin, a predominant matrix protein in glomerular expansion in diabetes (Fig. 4c,d). This evidence concerns the gene FN1 and diabetes mellitus.